The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Similar stories
6 outlets
See how this story developed, hour by hour
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results
finance.yahoo.com
19.08.2026
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
time.com
19.08.2026
BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
barrons.com
20.08.2026
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
marketwatch.com
19.08.2026
Moderna's Cancer Vaccine Could Change America in 7 Surprising Ways
newsweek.com
20.08.2026
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
aljazeera.com
19.08.2026
Related stories
Applied Materials’ China Problem Is Getting Worse
Vanguard Takes On Fidelity, Charles Schwab With $4 Billion Altruist Deal
Jamie Dimon Committed JPMorgan to $750 Billion of Housing Investment Through 2035
Health Care Roundup: Market Talk
Lumentum Climbs 4% as the AI Optics Trade Extends a Second Session, Coherent and Applied Optoelectronics Drift
Auto & Transport Roundup: Market Talk